Cannell & Spears’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Sell |
1,872
-37
| -2% | -$16.5K | 0.02% | 242 |
|
|
2025
Q1 | $926K | Sell |
1,909
-32
| -2% | -$15.5K | 0.02% | 229 |
|
|
2024
Q4 | $782K | Buy |
1,941
+3
| +0.2% | +$1.21K | 0.02% | 255 |
|
|
2024
Q3 | $901K | Sell |
1,938
-209
| -10% | -$97.2K | 0.02% | 249 |
|
|
2024
Q2 | $1.01M | Sell |
2,147
-380
| -15% | -$178K | 0.02% | 221 |
|
|
2024
Q1 | $1.06M | Buy |
+2,527
| New | +$1.06M | 0.02% | 222 |
|